Scilex Holding Co (SCLX) insider buying and SEC filings
Scilex Holding Co · CIK 1820190
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq, Nasdaq
- Industry (SIC)
- Biological Products, (No Diagnostic Substances)
- State of incorporation
- DE
- Fiscal year end
- Dec 31
- Former names
- Scilex Holding Company/DE; Vickers Vantage Corp. I
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$12.8M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 17, 2026 | Other purchase | Stephen Hoi Ma (CFO and Director) bought 650,000 Warrant (right to buy) at $0.1500 ($98K), reported as a purchase (code P). New position of 650,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Apr 16, 2026 | Other purchase | Henry Ji (CEO and Director) bought 3,250,000 Warrant (right to buy) at $0.1500 ($488K), reported as a purchase (code P). New position of 3,250,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 20, 2026 |
| Dec 26–30, 2025 | Sale | Holding Co Scilex (10% owner) sold 20,657,300 shares between Dec 26, 2025 and Dec 30, 2025 at about $0.6200 ($12.8M). Holdings down 8% to 244,445,260 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 30, 2025 |
2 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SCLX in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.